Opioid Crisis Hidden Truths

BARRIERS BREACHED: DEA Annual Production Quotas

4 min · 22. mai 2026
episode BARRIERS BREACHED: DEA Annual Production Quotas cover

Beskrivelse

The US drug crisis sees rising overdose deaths. We explore how DEA annual production quotas, often too lax, hinder efforts against the opioid crisis. This video examines barriers to DEA quotas, their impact on addiction treatment, and the role of law enforcement in the fentanyl crisis. We discuss neuroscience and addiction science, the devastating impact on communities, and the importance of Narcan. Understanding DEA quotas is key to a more effective system. The US military and veterans are also affected. By adapting quotas, we can better address addiction and public health.

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Opioid Crisis Hidden Truths sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

44 Episoder

episode Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS cover

Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS

The opioid crisis deeply impacts the US with rising overdose deaths fueled by fentanyl. We are tasked by the FDA with finding solutions to move past this OPIOID CRISIS!, and the FDA ombudsman plays a crucial, overlooked role. Examining opioid addiction science, brain models, and receptors can lead to solutions. Current guidelines may be insufficient, requiring bypassing bureaucracy for change. Observing near-death experiences and naloxone highlights the crisis's gravity. Rethinking our approach, with the FDA ombudsman key, combining law enforcement, neuroscience, and public health can create a future free from this crisis. Adrenaline and depression linked to addiction need a holistic approach using the latest science. FDA and CDC guidelines can form a framework for a new paradigm. The crisis's future depends on asking pertinent questions and seeking innovative solutions, with the FDA ombudsman integral.

11. juni 20263 min